Fungal and Bacterial Infections Research Group Publications

  1. Taxt AM, Eldholm V, Kols NI, Haugan MS, Raffelsberger N, Asfeldt AM, Ingebretsen A, Blomfeldt A, Kilhus KS, Lindemann PC, Bentele H, Stålcrantz J, Ødeskaug LE, Berg TC, Norwegian Serratia study group (2025)
    A national outbreak of Serratia marcescens complex: investigation reveals genomic population structure but no source, Norway, June 2021 to February 2023
    Euro Surveill, 30 (5)
    DOI 10.2807/1560-7917.ES.2025.30.5.2400291, PubMed 39916607
  2. Sharew B, Moges F, Yismaw G, Mihret A, Lobie TA, Abebe W, Fentaw S, Frye S, Vestrheim D, Tessema B, Caugant DA (2024)
    Molecular epidemiology of Streptococcus pneumoniae isolates causing invasive and noninvasive infection in Ethiopia
    Sci Rep, 14 (1), 21409
    DOI 10.1038/s41598-024-72762-9, PubMed 39271789
  3. Danielsen AS, Gu Q, Fostervold A, Eyre DW, Bjørnholt JV (2024)
    'Bloodstream infection': A valuable concept we should keep in our toolbox
    J Infect, 89 (4), 106236
    DOI 10.1016/j.jinf.2024.106236, PubMed 39097005
  4. Meijerink H, Veneti L, Kristoffersen AB, Danielsen AS, Stecher M, Starrfelt J (2024)
    Estimating vaccine effectiveness against COVID-19 using cause-specific sick leave as an indicator: a nationwide population-based cohort study, Norway, July 2021 - December 2022
    BMC Public Health, 24 (1), 1861
    DOI 10.1186/s12889-024-19374-0, PubMed 38992631
  5. Rolfsen MP, Gammelsrud KW, Espeland A, Bråten LC, Mjønes SB, Austevoll I, Dolatowski FC, Årrestad MB, Toppe MK, Orlien IE, Holberg-Petersen M, Fagerland M, Zwart JA, Storheim K, Hellum C (2024)
    Bacterial growth in patients with low back pain and Modic changes: protocol of a multicentre, case-control biopsy study
    BMJ Open, 14 (5), e082244
    DOI 10.1136/bmjopen-2023-082244, PubMed 38719329
  6. Fostervold A, Raffelsberger N, Hetland MAK, Bakksjø R, Bernhoff E, Samuelsen Ø, Sundsfjord A, Afset JE, Berntsen CF, Bævre-Jensen R, Ebbesen MH, Gammelsrud KW, Guleng AD, Handal N, Jakovljev A, Johal SK, Marvik Å, Natvik A, Sandnes RA, Tofteland S, Bjørnholt JV, Löhr IH, Assoc. on behalf of The Norwegian Study Group on Klebsiella pneumoniae (2024)
    Risk of death in Klebsiella pneumoniae bloodstream infections is associated with specific phylogenetic lineages
    J Infect, 88 (5), 106155
    DOI 10.1016/j.jinf.2024.106155, PubMed 38574775
  7. Oldereid TS, Jiang X, Nordhus KS, Ponzetta A, Bjørnholt JV, Björkström NK, Melum E, Rasmussen H (2023)
    Role of bacteria and microbial metabolites in immune modulation during early life
    Scand J Immunol, 99 (2), e13336
    DOI 10.1111/sji.13336, PubMed 38441196
  8. Danielsen AS, Nygaard NJ, Børseth AW, Nilsen JV, Øvreness H, Raastad R, Borg MA, Kacelnik O, Bjørnholt JV (2024)
    Patient perspectives on infection prevention and control in cancer care: a survey of knowledge and attitudes among persons with cancer and their next of kin
    J Hosp Infect, 146, 21-30
    DOI 10.1016/j.jhin.2024.01.012, PubMed 38311296
  9. Helset E, Cheng V, Sporsem H, Thorstensen C, Nordøy I, Gammelsrud KW, Hanssen G, Ponzi E, Lipman J, von der Lippe E (2024)
    Meropenem pharmacokinetic/pharmacodynamic target attainment and clinical response in ICU patients: A prospective observational study
    Acta Anaesthesiol Scand, 68 (4), 502-511
    DOI 10.1111/aas.14376, PubMed 38286568
  10. Al Rubaye M, Janice J, Bjørnholt JV, Löhr IH, Sundsfjord A, Hegstad K (2023)
    The first vanE-type vancomycin resistant Enterococcus faecalis isolates in Norway - phenotypic and molecular characteristics
    J Glob Antimicrob Resist, 36, 193-199
    DOI 10.1016/j.jgar.2023.12.021, PubMed 38154751
  11. Hegstad K, Pöntinen AK, Bjørnholt JV, Quist-Paulsen E, Sundsfjord A (2023)
    The first tigecycline resistant Enterococcus faecium in Norway was related to tigecycline exposure
    J Glob Antimicrob Resist, 36, 112-115
    DOI 10.1016/j.jgar.2023.12.002, PubMed 38122982
  12. Al Rubaye M, Janice J, Bjørnholt JV, Kacelnik O, Haldorsen BC, Nygaard RM, Hegstad J, Sundsfjord A, Hegstad K, The Norwegian Vre Study Group (2023)
    The population structure of vancomycin-resistant and -susceptible Enterococcus faecium in a low-prevalence antimicrobial resistance setting is highly influenced by circulating global hospital-associated clones
    Microb Genom, 9 (12)
    DOI 10.1099/mgen.0.001160, PubMed 38112685
  13. Heim AVBT, Janice J, Bjørnholt JV, Lunestad BT, Hegstad K, Svanevik CS (2023)
    Genomic insights into Enterococcus faecium isolates from marine bivalves highlight One Health concerns and healthcare linkages
    Microb Genom, 9 (12)
    DOI 10.1099/mgen.0.001154, PubMed 38085805
  14. Oldereid TS, Jiang X, Øgaard J, Schrumpf E, Bjørnholt JV, Rasmussen H, Melum E (2024)
    Microbial exposure during early life regulates development of bile duct inflammation
    Scand J Gastroenterol, 59 (2), 192-201
    DOI 10.1080/00365521.2023.2278423, PubMed 37997753
  15. Danielsen AS, Elstrøm P, Eriksen-Volle HM, Hofvind S, Eyre DW, Kacelnik O, Bjørnholt JV (2023)
    The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008-2018: expanding surveillance using existing laboratory and register data
    Eur J Clin Microbiol Infect Dis, 43 (1), 121-132
    DOI 10.1007/s10096-023-04698-3, PubMed 37980302
  16. Brendefur Corwin LM, Campbell P, Jakobsen K, Müller F, Lai X, Unemo M, Leegaard TM, Vildershøj Bjørnholt J, Olsen AO (2023)
    Improvement in Neisseria gonorrhoeae culture rates by bedside inoculation and incubation at a clinic for sexually transmitted infections
    Ann Clin Microbiol Antimicrob, 22 (1), 27
    DOI 10.1186/s12941-023-00576-0, PubMed 37072830
  17. Danielsen AS, Franconeri L, Page S, Myhre AE, Tornes RA, Kacelnik O, Bjørnholt JV (2023)
    Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
    BMC Infect Dis, 23 (1), 247
    DOI 10.1186/s12879-023-08182-3, PubMed 37072711
  18. Christensen I, Berild D, Bjørnholt JV, Jelsness-Jørgensen LP, Debes SM, Haug JB (2023)
    The Role of Procalcitonin as an Antimicrobial Stewardship Tool in Patients Hospitalized with Seasonal Influenza
    Antibiotics (Basel), 12 (3)
    DOI 10.3390/antibiotics12030573, PubMed 36978440
  19. Skagseth H, Danielsen AS, Kacelnik O, Trondsen UJ, Berg TC, Sorknes NK, Eriksen-Volle HM (2023)
    Clusters of healthcare-associated SARS-CoV-2 infections in Norwegian hospitals detected by a fully automatic register-based surveillance system
    J Hosp Infect, 135, 50-54
    DOI 10.1016/j.jhin.2023.02.014, PubMed 36913981
  20. Ravn C, Neyt J, Benito N, Abreu MA, Achermann Y, Bozhkova S, Coorevits L, Ferrari MC, Gammelsrud KW, Gerlach UJ, Giannitsioti E, Gottliebsen M, Jørgensen NP, Madjarevic T, Marais L, Menon A, Moojen DJ, Pääkkönen M, Pokorn M, Pérez-Prieto D, Renz N, Saavedra-Lozano J, Sabater-Martos M, Sendi P, Tevell S et al. (2023)
    Guideline for management of septic arthritis in native joints (SANJO)
    J Bone Jt Infect, 8 (1), 29-37
    DOI 10.5194/jbji-8-29-2023, PubMed 36756304
  21. Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2022)
    Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
    Breast Care (Basel), 17 (5), 486-494
    DOI 10.1159/000524564, PubMed 36684407
  22. Corwin LMB, Ingebretsen A, Campbell P, Alfsnes K, Müller F, Mauder N, Koomey M, Bjørnholt JV (2023)
    Fourier transform infrared spectroscopy; can it be used as a rapid typing method of Neisseria gonorrhoeae?
    J Microbiol Methods, 205, 106675
    DOI 10.1016/j.mimet.2023.106675, PubMed 36681126
  23. Rodríguez-Temporal D, Herrera L, Alcaide F, Domingo D, Héry-Arnaud G, van Ingen J, Van den Bossche A, Ingebretsen A, Beauruelle C, Terschlüsen E, Boarbi S, Vila N, Arroyo MJ, Méndez G, Muñoz P, Mancera L, Ruiz-Serrano MJ, Rodríguez-Sánchez B (2023)
    Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning
    J Clin Microbiol, 61 (1), e0111022
    DOI 10.1128/jcm.01110-22, PubMed 36602341
  24. Fraz MSA, Dahle G, Skaug KM, Jarraud S, Frye S, Bjørnholt JV, Nordøy I (2022)
    Case report: A prosthetic valve endocarditis caused by Legionella bozemanae in an immunocompetent patient
    Front Med (Lausanne), 9, 1055465
    DOI 10.3389/fmed.2022.1055465, PubMed 36405607
  25. Granerud BK, Ueland T, Lind A, Søraas A, Fevang B, Steffensen AK, Al-Baldawi H, Lund-Johansen F, Aukrust P, Halvorsen B, Dahl TB, Dudman S, Müller F, Holter JC (2022)
    Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
    Viruses, 14 (11)
    DOI 10.3390/v14112420, PubMed 36366518
  26. Starrfelt J, Danielsen AS, Kacelnik O, Wang Børseth A, Seppälä E, Meijerink H (2022)
    High vaccine effectiveness against coronavirus disease 2019 (COVID-19) and severe disease among residents and staff of long-term care facilities in Norway, November 2020-June 2021
    Antimicrob Steward Healthc Epidemiol, 2 (1), e10
    DOI 10.1017/ash.2021.246, PubMed 36310780
  27. Søraas A, Grødeland G, Granerud BK, Ueland T, Lind A, Fevang B, Murphy SL, Huse C, Nygaard AB, Steffensen AK, Al-Baldawi H, Holberg-Petersen M, Andresen LL, Ågnes C, Ranheim T, Schanke Y, Istre M, Dahl JA, Chopra A, Dudman S, Kaarbø M, Andersen JT, Vaage EB, Tran TT, Vaage JT et al. (2022)
    Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
    Front Immunol, 13, 964525
    DOI 10.3389/fimmu.2022.964525, PubMed 36159859
  28. Starrfelt J, Danielsen AS, Buanes EA, Juvet LK, Lyngstad TM, Rø GØI, Veneti L, Watle SV, Meijerink H (2022)
    Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021
    BMC Med, 20 (1), 278
    DOI 10.1186/s12916-022-02480-4, PubMed 36050718
  29. Danielsen AS, Cyr PR, Berg TC, Jønsberg E, Eriksen-Volle HM, Kacelnik O (2022)
    Register-based surveillance of COVID-19 in nursing homes
    Tidsskr Nor Laegeforen, 142 (8)
    DOI 10.4045/tidsskr.21.0906, PubMed 35635409
  30. Gladstone RA, McNally A, Pöntinen AK, Tonkin-Hill G, Lees JA, Skytén K, Cléon F, Christensen MOK, Haldorsen BC, Bye KK, Gammelsrud KW, Hjetland R, Kümmel A, Larsen HE, Lindemann PC, Löhr IH, Marvik Å, Nilsen E, Noer MT, Simonsen GS, Steinbakk M, Tofteland S, Vattøy M, Bentley SD, Croucher NJ et al. (2021)
    Emergence and dissemination of antimicrobial resistance in Escherichia coli causing bloodstream infections in Norway in 2002-17: a nationwide, longitudinal, microbial population genomic study
    Lancet Microbe, 2 (7), e331-e341
    DOI 10.1016/S2666-5247(21)00031-8, PubMed 35544167
  31. Avershina E, Frye SA, Ali J, Taxt AM, Ahmad R (2022)
    Ultrafast and Cost-Effective Pathogen Identification and Resistance Gene Detection in a Clinical Setting Using Nanopore Flongle Sequencing
    Front Microbiol, 13, 822402
    DOI 10.3389/fmicb.2022.822402, PubMed 35369431
  32. Christensen I, Berild D, Jelsness-Jørgensen LP, Bjørnholt JV, Haug JB (2022)
    [Tailored interventions result in better antimicrobial management in Norwegian hospitals]
    Tidsskr Nor Laegeforen, 142 (5)
    DOI 10.4045/tidsskr.22.0094, PubMed 35324115
  33. Moshina N, Aase HS, Danielsen AS, Haldorsen IS, Lee CI, Zackrisson S, Hofvind S (2022)
    Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial
    Radiology, 303 (1), E23
    DOI 10.1148/radiol.229003, PubMed 35312347
  34. Rodriguez-Temporal D, Alcaide F, Mareković I, O'Connor JA, Gorton R, van Ingen J, Van den Bossche A, Héry-Arnaud G, Beauruelle C, Orth-Höller D, Palacios-Gutiérrez JJ, Tudó G, Bou G, Ceyssens PJ, Garrigó M, González-Martin J, Greub G, Hrabak J, Ingebretsen A, Mediavilla-Gradolph MC, Oviaño M, Palop B, Pranada AB, Quiroga L, Ruiz-Serrano MJ et al. (2022)
    Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification
    Sci Rep, 12 (1), 1237
    DOI 10.1038/s41598-022-05315-7, PubMed 35075208
  35. Christensen I, Haug JB, Berild D, Bjørnholt JV, Skodvin B, Jelsness-Jørgensen LP (2022)
    Factors Affecting Antibiotic Prescription among Hospital Physicians in a Low-Antimicrobial-Resistance Country: A Qualitative Study
    Antibiotics (Basel), 11 (1)
    DOI 10.3390/antibiotics11010098, PubMed 35052975
  36. Oviaño M, Ingebretsen A, Steffensen AK, Croxatto A, Prod'hom G, Quiroga L, Bou G, Greub G, Rodríguez-Temporal D, Rodríguez-Sánchez B (2021)
    Multicenter Evaluation of Rapid BACpro® II for the Accurate Identification of Microorganisms Directly from Blood Cultures Using MALDI-TOF MS
    Diagnostics (Basel), 11 (12)
    DOI 10.3390/diagnostics11122251, PubMed 34943488
  37. Ramstad SN, Brandal LT, Taxt AM, Wasteson Y, Bjørnholt JV, Naseer U (2021)
    Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020
    J Med Microbiol, 70 (12)
    DOI 10.1099/jmm.0.001454, PubMed 34870582
  38. Størdal EH, Solevåg AL, Bjørnholt JV, Rønnestad A, Stensvold HJ (2021)
    Sepsis treatment options identified by 10-year study of microbial isolates and antibiotic susceptibility in a level-four neonatal intensive care unit
    Acta Paediatr, 111 (3), 519-526
    DOI 10.1111/apa.16189, PubMed 34787905
  39. Falk RS, Mariampillai JE, Prestgaard EE, Heir T, Bodegård J, Robsahm TE, Grundvold I, Skretteberg PT, Engeseth K, Bjornholt JV, Stavem K, Liestøl K, Sandvik L, Thaulow E, Erikssen G, Kjeldsen SE, Gjesdal K, Erikssen JE (2021)
    The Oslo Ischaemia Study: cohort profile
    BMJ Open, 11 (10), e049111
    DOI 10.1136/bmjopen-2021-049111, PubMed 34645662
  40. Ramstad SN, Wasteson Y, Lindstedt BA, Taxt AM, Bjørnholt JV, Brandal LT, Bohlin J (2021)
    Characterization of Shiga Toxin 2a Encoding Bacteriophages Isolated From High-Virulent O145:H25 Shiga Toxin-Producing Escherichia coli
    Front Microbiol, 12, 728116
    DOI 10.3389/fmicb.2021.728116, PubMed 34566932
  41. Al Rubaye MTS, Janice J, Bjørnholt JV, Jakovljev A, Hultström ME, Sundsfjord A, Hegstad K (2021)
    Novel genomic islands and a new vanD-subtype in the first sporadic VanD-type vancomycin resistant enterococci in Norway
    PLoS One, 16 (7), e0255187
    DOI 10.1371/journal.pone.0255187, PubMed 34297779
  42. Barratt-Due A, Olsen IC, Nezvalova-Henriksen K, Kåsine T, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Kildal AB, Berg Å, Johannessen A, Heggelund L, Dahl TB, Skåra KH, Mielnik P, Le LAK, Thoresen L, Ernst G, Hoff DAL, Skudal H, Kittang BR, Olsen RB et al. (2021)
    Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial
    Ann Intern Med, 174 (9), 1261-1269
    DOI 10.7326/M21-0653, PubMed 34251903
  43. Avershina E, Sharma P, Taxt AM, Singh H, Frye SA, Paul K, Kapil A, Naseer U, Kaur P, Ahmad R (2021)
    AMR-Diag: Neural network based genotype-to-phenotype prediction of resistance towards β-lactams in Escherichia coli and Klebsiella pneumoniae
    Comput Struct Biotechnol J, 19, 1896-1906
    DOI 10.1016/j.csbj.2021.03.027, PubMed 33897984
  44. Lossius AH, Sundnes O, Ingham AC, Edslev SM, Bjørnholt JV, Lilje B, Bradley M, Asad S, Haraldsen G, Skytt-Andersen P, Holm JØ, Berents TL (2021)
    Shifts in the Skin Microbiota after UVB Treatment in Adult Atopic Dermatitis
    Dermatology, 238 (1), 109-120
    DOI 10.1159/000515236, PubMed 33887725
  45. Molvik M, Danielsen AS, Grøsland M, Telle KE, Kacelnik O, Eriksen-Volle HM (2021)
    SARS-CoV-2 in health and care staff in Norway, 2020
    Tidsskr Nor Laegeforen, 141 (3)
    DOI 10.4045/tidsskr.20.1048, PubMed 33624971
  46. Ramstad SN, Taxt AM, Naseer U, Wasteson Y, Bjørnholt JV, Brandal LT (2020)
    Effects of antimicrobials on Shiga toxin production in high-virulent Shiga toxin-producing Escherichia coli
    Microb Pathog, 152, 104636
    DOI 10.1016/j.micpath.2020.104636, PubMed 33242644
  47. Christensen I, Haug JB, Berild D, Bjørnholt JV, Jelsness-Jørgensen LP (2020)
    Hospital physicians' experiences with procalcitonin - implications for antimicrobial stewardship; a qualitative study
    BMC Infect Dis, 20 (1), 515
    DOI 10.1186/s12879-020-05246-6, PubMed 32677903
  48. Helset E, Nordøy I, Sporsem H, Bakke VD, Bugge JF, Gammelsrud KW, Zucknick M, von der Lippe E (2020)
    Factors increasing the risk of inappropriate vancomycin therapy in ICU patients: A prospective observational study
    Acta Anaesthesiol Scand, 64 (9), 1295-1304
    DOI 10.1111/aas.13658, PubMed 32578201
  49. Taxt AM, Avershina E, Frye SA, Naseer U, Ahmad R (2020)
    Rapid identification of pathogens, antibiotic resistance genes and plasmids in blood cultures by nanopore sequencing
    Sci Rep, 10 (1), 7622
    DOI 10.1038/s41598-020-64616-x, PubMed 32376847
  50. Berg MS, Straiton ML, Vikum EF, Myhre SL, Danielsen AS, Gopinathan U (2020)
    [Asylum seekers’ health and use of health services in Norway]
    Tidsskr Nor Laegeforen, 140 (4)
    DOI 10.4045/tidsskr.19.0470, PubMed 32192269
  51. Shaw HA, Preston MD, Vendrik KEW, Cairns MD, Browne HP, Stabler RA, Crobach MJT, Corver J, Pituch H, Ingebretsen A, Pirmohamed M, Faulds-Pain A, Valiente E, Lawley TD, Fairweather NF, Kuijper EJ, Wren BW (2019)
    The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics
    Clin Microbiol Infect, 26 (4), 492-498
    DOI 10.1016/j.cmi.2019.09.004, PubMed 31525517
  52. Berdal JE, Follin-Arbelet B, Bjørnholt JV (2019)
    Experiences from multiplex PCR diagnostics of faeces in hospitalised patients: clinical significance of Enteropathogenic Escherichia coli (EPEC) and culture negative campylobacter
    BMC Infect Dis, 19 (1), 630
    DOI 10.1186/s12879-019-4271-1, PubMed 31315581
  53. Di Ruscio F, Guzzetta G, Bjørnholt JV, Leegaard TM, Moen AEF, Merler S, Freiesleben de Blasio B (2019)
    Quantifying the transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country
    Proc Natl Acad Sci U S A, 116 (29), 14599-14605
    DOI 10.1073/pnas.1900959116, PubMed 31262808
  54. Knudsen PK, Gammelsrud KW, Alfsnes K, Steinbakk M, Abrahamsen TG, Müller F, Bohlin J (2018)
    Transfer of a bla CTX-M-1-carrying plasmid between different Escherichia coli strains within the human gut explored by whole genome sequencing analyses
    Sci Rep, 8 (1), 280
    DOI 10.1038/s41598-017-18659-2, PubMed 29321570
  55. Di Ruscio F, Bjørnholt JV, Larssen KW, Leegaard TM, Moen AE, de Blasio BF (2017)
    Epidemiology and spa-type diversity of meticillin-resistant Staphylococcus aureus in community and healthcare settings in Norway
    J Hosp Infect, 100 (3), 316-321
    DOI 10.1016/j.jhin.2017.12.019, PubMed 29288777
  56. Alcaide F, Amlerová J, Bou G, Ceyssens PJ, Coll P, Corcoran D, Fangous MS, González-Álvarez I, Gorton R, Greub G, Hery-Arnaud G, Hrábak J, Ingebretsen A, Lucey B, Marekoviċ I, Mediavilla-Gradolph C, Monté MR, O'Connor J, O'Mahony J, Opota O, O'Reilly B, Orth-Höller D, Oviaño M, Palacios JJ, Palop B et al. (2017)
    How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry
    Clin Microbiol Infect, 24 (6), 599-603
    DOI 10.1016/j.cmi.2017.11.012, PubMed 29174730
  57. Knudsen PK, Brandtzaeg P, Høiby EA, Bohlin J, Samuelsen Ø, Steinbakk M, Abrahamsen TG, Müller F, Gammelsrud KW (2017)
    Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting
    PLoS One, 12 (11), e0187618
    DOI 10.1371/journal.pone.0187618, PubMed 29112974
  58. Johnsen BO, Handal N, Meisal R, Bjørnholt JV, Gaustad P, Leegaard TM (2017)
    erm gene distribution among Norwegian Bacteroides isolates and evaluation of phenotypic tests to detect inducible clindamycin resistance in Bacteroides species
    Anaerobe, 47, 226-232
    DOI 10.1016/j.anaerobe.2017.06.004, PubMed 28602805
  59. Mandal S, Godfrey KM, McDonald D, Treuren WV, Bjørnholt JV, Midtvedt T, Moen B, Rudi K, Knight R, Brantsæter AL, Peddada SD, Eggesbø M (2016)
    Fat and vitamin intakes during pregnancy have stronger relations with a pro-inflammatory maternal microbiota than does carbohydrate intake
    Microbiome, 4 (1), 55
    DOI 10.1186/s40168-016-0200-3, PubMed 27756413
  60. Gammelsrud KW, Knudsen PK, Høiby EA (2016)
    A novel Direct MIC-gradient Strip Method to screen for antibiotic-resistant faecal Enterobacteriaceae
    J Microbiol Methods, 129, 94-97
    DOI 10.1016/j.mimet.2016.08.007, PubMed 27526992
  61. van Dorp SM, Kinross P, Gastmeier P, Behnke M, Kola A, Delmée M, Pavelkovich A, Mentula S, Barbut F, Hajdu A, Ingebretsen A, Pituch H, Macovei IS, Jovanović M, Wiuff C, Schmid D, Olsen KE, Wilcox MH, Suetens C, Kuijper EJ, European Clostridium difficile Infection Surveillance Network (ECDIS-Net) on behalf of all participants (2016)
    Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013
    Euro Surveill, 21 (29)
    DOI 10.2807/1560-7917.ES.2016.21.29.30293, PubMed 27472820
  62. Andersen KM, Kristoffersen AK, Ingebretsen A, Vikholt KJ, Örtengren UT, Olsen I, Enersen M, Gaustad P (2016)
    Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates
    J Oral Microbiol, 8, 29849
    DOI 10.3402/jom.v8.29849, PubMed 26861194
  63. Nilsen E, Haldorsen BC, Sundsfjord A, Simonsen GS, Ingebretsen A, Naseer U, Samuelsen O, Norwegian Study Group on Invasive Enterobacter (2013)
    Large IncHI2-plasmids encode extended-spectrum β-lactamases (ESBLs) in Enterobacter spp. bloodstream isolates, and support ESBL-transfer to Escherichia coli
    Clin Microbiol Infect, 19 (11), E516-8
    DOI 10.1111/1469-0691.12274, PubMed 23800169
  64. Gammelsrud KW, Lindstad BL, Gaustad P, Ingebretsen A, Høiby EA, Brandtzaeg P, Sandven P (2012)
    Multilocus sequence typing of serial Candida albicans isolates from children with cancer, children with cystic fibrosis and healthy controls
    Med Mycol, 50 (6), 619-26
    DOI 10.3109/13693786.2012.675088, PubMed 22524637
  65. Kvakkestad KM, Gammelsrud KW, Brandtzaeg P, Høiby EA (2012)
    Unchanged antibiotic susceptibility in Escherichia coli and Pseudomonas aeruginosa after long-term in vitro exposure to antineoplastic drugs
    Chemotherapy, 58 (2), 118-22
    DOI 10.1159/000337058, PubMed 22507969
  66. Høiby EA, Vestrheim DF, Caugant DA, Gammelsrud KW (2008)
    [Bacterial resistance against antibiotics]
    Tidsskr Nor Laegeforen, 128 (21), 2452-6
    PubMed 19096468
  67. Granslo H, Gammelsrud KW, Fredheim EA, Flaegstad T, Klingenberg C (2008)
    [Coagulase-negative staphylococci--biofilm and antibiotic resistance]
    Tidsskr Nor Laegeforen, 128 (23), 2746-9
    PubMed 19079425
  68. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, Drudy D, Fitzpatrick F, Wiuff C, Brown DJ, Coia JE, Pituch H, Reichert P, Even J, Mossong J, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Delmée M, Coignard B, Wilcox M, Patel B, Frei R, Nagy E et al. (2008)
    Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
    Euro Surveill, 13 (31)
    PubMed 18761903
  69. Stabell N, Nordal E, Stensvold E, Gammelsrud KW, Lund B, Taxt A, Buhring F, Greve-Isdahl M, Fornebo HP, Simonsen GS, Klingenberg C (2008)
    Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome
    Scand J Infect Dis, 40 (4), 301-7
    DOI 10.1080/00365540701670436, PubMed 17918015
  70. Berdal JE, Smith-Erichsen N, Bjørnholt JV, Blomfeldt A, Bukholm G (2006)
    Does Pseudomonas aeruginosa colonization influence morbidity and mortality in the intensive care unit patient? Experience from an outbreak caused by contaminated oral swabs
    Acta Anaesthesiol Scand, 50 (9), 1095-102
    DOI 10.1111/j.1399-6576.2006.01044.x, PubMed 16987339
  71. Berdal JE, Skråmm I, Mowinckel P, Gulbrandsen P, Bjørnholt JV (2005)
    Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections
    Clin Microbiol Infect, 11 (10), 843-5
    DOI 10.1111/j.1469-0691.2005.01230.x, PubMed 16153261
  72. Bodegard J, Erikssen G, Bjørnholt JV, Gjesdal K, Liestøl K, Erikssen J (2005)
    Reasons for terminating an exercise test provide independent prognostic information: 2014 apparently healthy men followed for 26 years
    Eur Heart J, 26 (14), 1394-401
    DOI 10.1093/eurheartj/ehi278, PubMed 15855193
  73. Stavem K, Aaser E, Sandvik L, Bjørnholt JV, Erikssen G, Thaulow E, Erikssen J (2005)
    Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males
    Eur Respir J, 25 (4), 618-25
    DOI 10.1183/09031936.05.00008504, PubMed 15802334
  74. Yaqub S, Bjørnholt JV, Enger AE (2004)
    [Tularemia from a cat bite]
    Tidsskr Nor Laegeforen, 124 (24), 3197-8
    PubMed 15608764
  75. Yaqub S, Bjørnholt JV, Hellum KB, Steinbakk M, Enger AE (2004)
    [Bite wound infections]
    Tidsskr Nor Laegeforen, 124 (24), 3194-6
    PubMed 15608763
  76. Bodegard J, Erikssen G, Bjørnholt JV, Gjesdal K, Thelle D, Erikssen J (2004)
    Symptom-limited exercise testing, ST depressions and long-term coronary heart disease mortality in apparently healthy middle-aged men
    Eur J Cardiovasc Prev Rehabil, 11 (4), 320-7
    DOI 10.1097/01.hjr.0000136460.57921.46, PubMed 15292766
  77. Erikssen G, Bodegard J, Bjørnholt JV, Liestøl K, Thelle DS, Erikssen J (2004)
    Exercise testing of healthy men in a new perspective: from diagnosis to prognosis
    Eur Heart J, 25 (11), 978-86
    DOI 10.1016/j.ehj.2004.04.009, PubMed 15172470
  78. Bodegard J, Erikssen G, Bjornholt JV, Thelle D, Erikssen J (2004)
    Possible angina detected by the WHO angina questionnaire in apparently healthy men with a normal exercise ECG: coronary heart disease or not? A 26 year follow up study
    Heart, 90 (6), 627-32
    DOI 10.1136/hrt.2003.012542, PubMed 15145862
  79. Bodegard J, Erikssen G, Sandvik L, Kjeldsen SE, Bjørnholt J, Erikssen JE (2002)
    Early versus late morning measurement of blood pressure in healthy men. A potential source of measurement bias?
    Blood Press, 11 (6), 366-70
    DOI 10.1080/080370502321095339, PubMed 12523680
  80. Erikssen G, Liestøl K, Bjørnholt JV, Thaulow E, Erikssen J (2000)
    Hypothesis: the recent decline in coronary heart disease mortality--mainly a shift from fatal to non-fatal events?
    Scand Cardiovasc J, 34 (5), 468-74
    DOI 10.1080/140174300750064620, PubMed 11191936
  81. Erikssen G, Liestøl K, Bjørnholt JV, Stormorken H, Thaulow E, Erikssen J (2000)
    Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality
    Eur Heart J, 21 (19), 1614-20
    DOI 10.1053/euhj.2000.2148, PubMed 10988014
  82. Bjørnholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, Jervell J, Erikssen J, Thaulow E (1999)
    Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men
    Diabetes Care, 22 (1), 45-9
    DOI 10.2337/diacare.22.1.45, PubMed 10333902
  83. Lindemann PC, Gammelsrud KW, Lohr IH, Akselsen PE, Lindbaek M, Sundsfjord A (2019)
    Selection of antibiotics-important change in sample response from the microbiologist
    Tidsskr. Nor. Laegeforen., 139 (12), 1132-1133

 
Scroll to top